Scott Trevino Promoted to Senior VP Product Management and Solutions at TRIMEDX

Scott Trevino has been promoted to senior vice president of product management and solutions at TRIMEDX, effective immediately.

In his new role, Scott Trevino will partner across the organization to develop, drive and execute the product strategy for TRIMEDX’s technology and analytics portfolio. He will serve as a member of the TRIMEDX executive leadership team reporting to Chief Marketing Officer LeAnne Hester.

Trevino and his team will manage the TRIMEDX portfolio to align with business strategy and outcomes, product innovation and development prioritization. This portfolio combines technology-enabled, best-in-class clinical engineering and cybersecurity with next-generation clinical asset management to transform a health system’s medical devices into a strategic lever for improving overall performance.

“We have been fortunate to have Scott as an integral member of our TRIMEDX team to drive a number of our key initiatives over the last two years,” says LeAnne Hester, chief marketing officer. “His experience in product management, regulatory, risk management and leadership will continue to advance our commitment to develop solutions that enable our clients to reduce cost and their overall risk.”

Trevino joined TRIMEDX in 2018 as vice president of quality assurance, regulatory and technology and has helped contribute to and drive key initiatives around cybersecurity, product development and recalls, as well as to establish the TRIMEDX brand and influence in the industry through his work establishing relationships with regulatory agencies and industry organizations such as the Association for the Advancement of Medical Instrumentation and with the Alliance for Quality Medical Device Servicing.

“I’m looking forward to becoming part of an extremely talented team with a clear vision for the future and a fantastic leader,” says Trevino. “I have a deep passion for our clients and the patients they serve. Together, we have the privilege to continue helping provide meaningful solutions for the providers, the clinicians and their patients.”

Prior to joining TRIMEDX, Trevino spent over 20 years at GE Healthcare holding multiple leadership positions in product management, service, technology/engineering, operations and quality. He has led successful transformative change across organizations by leveraging his unique experience, expertise and analytical approach. He is Six Sigma Lean Black Belt-certified with a history of success in executing complex global strategies and has a passion for developing, motivating and leading teams.

Trevino earned an MBA from The University of Chicago Booth School of Business, as well as a Master of Science in Computing, Bachelor of Science in Computer Science and Bachelor of Arts in Psychology from Marquette University.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.